Mad in America

MARCH 21, 2024

O n 3 August 2023, I wrote to the editors of two medical journals and called for retraction of three fraudulent reports of placebo-controlled trials of depression drugs in children and adolescents. Copenhagen: Institute for Scientific Freedom 2023;Nov 14. This is fraud. Arch Gen Psychiatry 2006;63:332-9. 17 Gøtzsche PC.

Manufacturing 145

Manufacturing Self-awareness Legal Personality disorders 145

Mad in America

AUGUST 5, 2024

The same is true of attempts to reframe other diagnostic labels as ‘identities’—including the most contentious, ‘borderline personality disorder’ which, it is suggested, can be ‘destigmatised’ through ‘ neuroqueer feminism ’. Neuroqueer Feminism: Turning with Tenderness toward Borderline Personality Disorder. Johnson, M.

Trauma and the brain 143

Trauma and the brain Genetics and mental health Self-awareness Personality disorders 143

Mad in America

DECEMBER 18, 2024

The new drug application for MDMA-AT submitted by MAPS would have allowed MDMA legal use solely within MAPS’ proprietary psychotherapy protocol and only for individuals with a PTSD diagnosis. In 2023, Dryer resigned her medical license. Ingrascis impact on the field cannot be understated.

Psychedelic therapy 114

Psychedelic therapy Legal Aging and mental health Self-awareness 114